Table 2 Methodology and reporting assessment
From: Corticosteroid use and intensive care unit-acquired weakness: a systematic review and meta-analysis
Cochrane Collaboration tool for assessing risk of bias | |||||||||
Study | Sequence generation | Allocation concealment | Blinding of participants, personnel, and outcome assessors | Incomplete outcome data | Selective outcome reporting | Other potential threats to validity | Risk of bias | ||
Keh et al., 2016 [18] | Y | Y | Y | Â | Y | Y | Y | Â | Low |
Newcastle–Ottawa quality assessment scale for cohort studies | |||||||||
Study | Selection | Comparability | Outcome | Score | |||||
| Â | Exposed representative? | Nonexposed representative? | Ascertainment of exposure | Outcome of interest not present at start | Â | Assessment of outcome | Adequate duration of follow-up | Completeness of follow-up | Â |
Gupta and Mishra, 2016 [19] | Y | Y | Y | Y | Y, Y | Y | Y | Y | 9 |
Nguyen The and Nguyen Huu, 2015 [1] | Y | Y | Y | Y | N, N | Y | Y | Y | 7 |
Wieskeet al., 2014 [20] | Y | Y | Y | Y | N, N | Y | Y | Y | 7 |
Patel et al., 2014 [21] | Y | Y | Y | Y | N, N | Y | Y | Y | 7 |
Anastasopoulos et al., 2011 [22] | Y | Y | Y | Y | N, N | Y | Y | Y | 7 |
Brunello et al., 2010 [24] | Y | Y | Y | Y | Y, Y | N | Y | N | 7 |
Sharshar et al., 2010 [23] | Y | Y | Y | Y | N, N | N | Y | Y | 6 |
Weber-Carstens et al., 2009 [25] | Y | Y | Y | Y | N, N | Y | Y | Y | 7 |
Nanas et al., 2008 [26] | Y | Y | Y | Y | N, N | N | Y | Y | 6 |
Ali et al., 2008 [27] | Y | Y | Y | Y | N, N | Y | Y | Y | 7 |
Hermans et al., 2007 [28] | Y | Y | Y | Y | N, N | Y | Y | Y | 7 |
Khan et al., 2006 [30] | Y | Y | Y | Y | N, N | Y | Y | N | 6 |
Lefaucheur et al., 2006 [29] | Y | Y | Y | Y | N, N | Y | Y | Y | 7 |
De Jonghe et al., 2002 [31] | Y | Y | Y | Y | Y, Y | Y | Y | Y | 9 |
de Letter et al., 2001 [33] | Y | Y | Y | Y | N, N | N | Y | Y | 6 |
Garnacho-Montero et al., 2001 [32] | Y | Y | Y | Y | N, N | Y | Y | Y | 7 |
Coakley et al., 1998 [34] | Y | Y | Y | Y | N, N | Y | Y | Y | 7 |